TRIUMF and CNL Form Strategic Partnership to Enable Ground-Breaking Cancer Treatment

Leading Canadian laboratories collaborate to produce Actinium-225, a rare medical isotope with the potential to revolutionize the fight against untreatable forms of cancer.

Read the Press Release Here